Pharmare SRL
Pharmare reported total assets of €1.29m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Nov 2025).
The score of Pharmare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmare's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 161,633 € | ||||
| Equity | 578,365 € | ||||
| Cash | 47,686 € | ||||
| EBITDA | 273,722 € | ||||
| Total assets | €1.29m |
Filed annual accounts
- Year ended 31 Mar 2025filed on 27 Nov 2025
- Year ended 31 Mar 2024filed on 30 Nov 2024
- Year ended 31 Mar 2023filed on 14 Sep 2023
- Year ended 31 Mar 2022filed on 07 Nov 2022
- Year ended 31 Mar 2021filed on 14 Oct 2021
Pharmare's financial analysis
- Solvency44.9%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmare
Pharmare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0553.716.481
- VAT number
- BE0553716481
- Peppol
- Registered · 0208:0553716481 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jun 2014
- Registered office
- 8420 De Haan
- Latest accounts
- 2025 · filed on 27 Nov 2025
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmare (SRL) has been based in De Haan since 2014, active in: business and other management consultancy activities. For 2025, it reports a net profit of 161,633 € and equity of 578,365 €; its revenue is not published. Its solvency stands at 44.9%, below the median of its sector (58.9%).
Companies similar to Pharmare
Companies in the same business, of comparable size and area, outside its group.
- Wouters Management Business and other management consultancy activities Beringen · balance sheet €1.29m
- MF Management Business and other management consultancy activities Fléron · balance sheet €1.29m
- Delpharm Business and other management consultancy activities Amay · balance sheet €1.29m
- THE Concord Group Business and other management consultancy activities Leuven · balance sheet €1.29m
- Amlibo Business and other management consultancy activities Ninove · balance sheet €1.29m
- LeaP Management Business and other management consultancy activities Rixensart · balance sheet €1.86m
- Retail LMC Business and other management consultancy activities Étalle · balance sheet €1.34m
- Galwico Business and other management consultancy activities Tongeren-Borgloon · balance sheet €1.29m
Frequently asked questions about Pharmare
What is the revenue of Pharmare?
Pharmare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmare?
In Belgium, the VAT number is the company number prefixed with BE: BE0553716481 for Pharmare, if the company is VAT-registered. Its company number (CBE) is 0553.716.481.
Where is the registered office of Pharmare?
According to the CBE register, the registered office of Pharmare is in 8420 De Haan.
What is the equity of Pharmare?
At the close of the 2025 financial year, the equity of Pharmare amounts to 578,365 €, a solvency of 44.9% of total assets.
Who manages Pharmare?
The register lists 2 active mandates at Pharmare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →